Australia, May 31 -- Athena Medtec Ltd., owns the trademark (2497989) for 'TOXBAR' till Nov. 12, 2034.

Status: registered: Registered/protected

Classes: 5 [Hyaluronic acid based barrier substance injected between prostate and rectum to mitigate the toxicity effects of radiotherapy treatments of prostate cancer; gel substance injected between prostate and rectum for creating a space between the two for protecting the rectum from radiation during prostate cancer radiation treatment; a barrier product to create a space between the prostate and the rectal wall to minimise the risk of radiation toxicity impacting on the rectum during radiotherapy treatment for prostate cancer], 10 [Medical devices, namely, synthetic implants in the nature of a hyaluronic acid based barrier substance injected between prostate and rectum to mitigate the toxicity effects of radiotherapy treatments of prostate cancer; Medical devices, namely, synthetic implants in the nature of a gel injected between prostate and rectum for creating a space between the two for protecting the rectum from radiation during prostate cancer radiation treatment; kits that contain applicators consisting of a needle and a hyaluronic acid based substance for use in medical and surgical procedures; surgical and medical apparatus and instruments; a medical barrier device to create a space between the prostate and the rectal wall to minimise the risk of radiation toxicity impacting on the rectum during radiotherapy treatment for prostate cancer], 5 [Hyaluronic acid based barrier substance injected between prostate and rectum to mitigate the toxicity effects of radiotherapy treatments of prostate cancer;gel substance injected between prostate and rectum for creating a space between the two for protecting the rectum from radiation during prostate cancer radiation treatment;a barrier product to create a space between the prostate and the rectal wall to minimise the risk of radiation toxicity impacting on the rectum during radiotherapy treatment for prostate cancer] and 10 [Medical devices, namely, synthetic implants in the nature of a hyaluronic acid based barrier substance injected between prostate and rectum to mitigate the toxicity effects of radiotherapy treatments of prostate cancer;Medical devices, namely, synthetic implants in the nature of a gel injected between prostate and rectum for creating a space between the two for protecting the rectum from radiation during prostate cancer radiation treatment;kits that contain applicators consisting of a needle and a hyaluronic acid based substance for use in medical and surgical procedures;surgical and medical apparatus and instruments;a medical barrier device to create a space between the prostate and the rectal wall to minimise the risk of radiation toxicity impacting on the rectum during radiotherapy treatment for prostate cancer]

Type of Mark: Word

Date of Acceptance: Nov. 15, 2024

Registration Advertised: May 30

For further details contact PHILLIPS ORMONDE FITZPATRICK.

The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2497989.

Disclaimer: Curated by HT Syndication.